Item Number: ERYSENG
Eryseng is a veterinary vaccine that contains inactivated (killed) Erysipelothrix rhusiopathiae bacteria. It contains a bacterial strain called R32E11. Eryseng is available as a suspension for injection.
Eryseng is used to protect male and female pigs against swine erysipelas caused by Erysipelothrix rhusiopathiae bacteria of specific types called serotype 1 and serotype 2. Swine erysipelas is a bacterial disease of pigs characterised by sudden death, fever associated with diamond skin lesions, arthritis and by abortion in pregnant sows.
The vaccine is given to pigs from six months of age as an injection into the neck muscles, repeated after three to four weeks. A single injection is given two to three weeks before each mating so approximately every six months.
Eryseng is a bacterial vaccine. Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease. When Eryseng is given to pigs the animals’ immune system recognises the bacteria as ‘foreign’ and makes antibodies against them. In the future, if the animals are exposed to Erysipelothrix rhusiopathiae bacteria, the immune system will be able to respond more quickly. This will help protect them against swine erysipelas.
Eryseng contains an adjuvant (aluminium hydroxide, DEAE-dextran and ginseng) to enhance the immune response.
The most common side effect (seen in more than 1 in 10 pigs) with Eryseng is mild to moderate inflammation at the injection site, which typically resolves within four days but in some cases may persist for up to 12 days post-vaccination.
In case of accidental self-injection, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
ERYSENG 25D: Data Sheet